Why I Still Wouldn't Buy Nike Stock in November

Nike reported fiscal 2027 first-quarter revenue of $11.2 billion, down 4% year over year, and net income of $712 million, down 2%; it also announced a restructuring plan expected to result in layoffs and forecast a high-single-digit percentage decline in full-year 2027 revenue. Shares were down around 39% in 2026 as of the article, with no immediate catalysts identified. Nike’s dividend yields 4.2% and has increased annually for 24 years; CFO Dave Denton said maintaining and ultimately growing it remains a significant priority, but the article argues weak sales make the stock unattractive for now.

Analysis

The 4.2% yield is a price signal as much as an income signal: the share-price decline has lifted it while the operating outlook is deteriorating. Management’s stated dividend priority is not evidence that the payout is covered through the downturn. The key missing checks are free-cash-flow coverage after restructuring and business investment, inventory/markdown trends, and whether working-capital needs are consuming cash. A dividend increase could preserve the streak while leaving less capacity to fund product, marketing, and channel repair.

Near term, the high-single-digit FY27 revenue decline guidance limits the case for a quick rerating; a dividend-oriented buyer may also be disappointed if the stock remains volatile rather than behaving like a defensive income holding. Over 1–3 months, watch earnings revisions, gross-margin direction, and inventory clearance. Over 6–18 months, a successful return to wholesale distribution and product relevance could improve sell-through, but aggressive discounting to regain share could pressure margins across sportswear and retailers, including Adidas and Under Armour. That competitive spillover is a risk to the whole category, not proof of NKE-specific share gains.

Contrarian angle: expectations may already be sufficiently depressed that merely less-bad sales and cleaner inventories could support a rebound; the article’s no-catalyst framing may underweight that optionality. But a yield alone does not establish a floor. No valuation or cash-flow data here supports a compelling entry price.

Key Decisions for Investors

• Do not buy NKE solely for the stated yield. Treat the dividend as conditional on cash generation; verify free-cash-flow coverage, payout ratio, and post-restructuring cash needs before underwriting it as an income position.
• Near term, keep NKE on watch rather than initiating a directional trade on this evidence. Reassess after the next earnings update for revenue versus guidance, inventory/markdowns, gross margin, and any change in dividend language.
• A contrarian long becomes more credible if sell-through stabilizes and cash-flow coverage remains intact despite the sales decline. Falsify that thesis on another deterioration in guidance, persistent inventory clearance, or reduced dividend growth/coverage.
• For existing exposure, size against downside in both earnings expectations and dividend confidence; the current yield is not a reliable hedge against further multiple compression.